{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T21:23:55Z","timestamp":1783027435723,"version":"3.54.6"},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017547","name":"Spark Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017547","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","award":["MR\/ Y014987 \/1"],"award-info":[{"award-number":["MR\/ Y014987 \/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005239","name":"Indian Health Service","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005239","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Neurosciences"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.tins.2026.02.002","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T21:08:45Z","timestamp":1772226525000},"page":"157-158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["CHCHD2 links mitochondrial dysfunction and \u03b1-synuclein misfolding in Parkinson\u2019s disease"],"prefix":"10.1016","volume":"49","author":[{"given":"Derek","family":"Narendra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6703-3718","authenticated-orcid":false,"given":"Brent J.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tins.2026.02.002_bb0005","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adu0726","article-title":"CHCHD2 mutant mice link mitochondrial deficits to PD pathophysiology","volume":"11","author":"Liao","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.tins.2026.02.002_bb0010","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1093\/hmg\/ddz241","article-title":"Mutations in CHCHD2 cause \u03b1-synuclein aggregation","volume":"28","author":"Ikeda","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tins.2026.02.002_bb0015","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/hmg\/ddaa077","article-title":"Loss of CHCHD2 and CHCHD10 activates OMA1 peptidase to disrupt mitochondrial cristae phenocopying patient mutations","volume":"29","author":"Liu","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tins.2026.02.002_bb0020","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00401-019-01989-y","article-title":"ALS\/FTD mutant CHCHD10 mice reveal a tissue-specific toxic gain-of-function and mitochondrial stress response","volume":"138","author":"Anderson","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tins.2026.02.002_bb0025","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00401-019-01988-z","article-title":"Mitochondrial defect in muscle precedes neuromuscular junction degeneration and motor neuron death in CHCHD10(S59L\/+) mouse","volume":"138","author":"Genin","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tins.2026.02.002_bb0030","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1172\/JCI129987","article-title":"Enhancing glycolysis attenuates Parkinson\u2019s disease progression in models and clinical databases","volume":"129","author":"Cai","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tins.2026.02.002_bb0035","first-page":"3881","article-title":"CHCHD2 accumulates in distressed mitochondria and facilitates oligomerization of CHCHD10","volume":"27","author":"Huang","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tins.2026.02.002_bb0040","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000394","article-title":"Neuropathologic description of CHCHD10 mutated amyotrophic lateral sclerosis","volume":"6","author":"Keith","year":"2020","journal-title":"Neurol. Genet."},{"key":"10.1016\/j.tins.2026.02.002_bb0045","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1523\/JNEUROSCI.1478-20.2021","article-title":"REST protects dopaminergic neurons from mitochondrial and alpha-synuclein oligomer pathology in an alpha synuclein overexpressing BAC-transgenic mouse model","volume":"41","author":"Ryan","year":"2021","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2026.02.002_bb0050","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1093\/brain\/awt160","article-title":"Mesencephalic complex I deficiency does not correlate with parkinsonism in mitochondrial DNA maintenance disorders","volume":"136","author":"Palin","year":"2013","journal-title":"Brain"}],"container-title":["Trends in Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166223626000263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166223626000263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T21:09:02Z","timestamp":1783026542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166223626000263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0166223626000263"],"URL":"https:\/\/doi.org\/10.1016\/j.tins.2026.02.002","relation":{},"ISSN":["0166-2236"],"issn-type":[{"value":"0166-2236","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CHCHD2 links mitochondrial dysfunction and \u03b1-synuclein misfolding in Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Trends in Neurosciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tins.2026.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}